Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

Sun Pharmaceutical Industries Limited · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
prostatesensitive
metastatic cancer, neoplasm, prostate, castrate-sensitive, castrate-sensitive prostate cancer, yonsa, zytiga, enzalutamide, apalutamide, growth rate, doubling time, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 907801
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.